Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
160M
-
Number of holders
-
234
-
Total 13F shares, excl. options
-
93.7M
-
Shares change
-
+10.1M
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$128M
-
Put/Call ratio
-
1.37
-
Number of buys
-
100
-
Number of sells
-
-94
-
Price
-
$12.63
Significant Holders of NOVAVAX INC - Common Stock (NVAX) as of Q3 2024
309 filings reported holding NVAX - NOVAVAX INC - Common Stock as of Q3 2024.
NOVAVAX INC - Common Stock (NVAX) has 234 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.7M shares
of 160M outstanding shares and own 58.53% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15.4M shares), BlackRock, Inc. (12.5M shares), SHAH CAPITAL MANAGEMENT (9.82M shares), STATE STREET CORP (7.69M shares), D. E. Shaw & Co., Inc. (5.94M shares), GEODE CAPITAL MANAGEMENT, LLC (3.5M shares), BANK OF MONTREAL /CAN/ (2.45M shares), COATUE MANAGEMENT LLC (2.22M shares), RENAISSANCE TECHNOLOGIES LLC (2.06M shares), and TWO SIGMA ADVISERS, LP (2M shares).
This table shows the top 234 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.